Category Snapshot
99.9% Accuracy
Our advanced regulatory translation and writing models achieve industry-leading precision for global submissions.
ISO Certified
Fully compliant with ISO 9001, 27001, 27017, 27018, and 27701 for maximum data security and privacy.
Global Presence
Serving over 1,000 pharmaceutical companies including Bayer, BMS, MSD, Roche, and JJMC across Asia and the West.
Full CTD Coverage
Automated support for CSRs, Protocols, IBs, Safety Narratives, and post-marketing documentation.
Expert Supervision
A team of 200+ professionals, including 70+ full-time translators and medical writers from top pharma firms.
Rapid Turnaround
Achieve up to 92% faster delivery compared to traditional industry benchmarks for large-scale projects.
Core AI Writing Modules
AI-Driven CTD Documentation Coverage
Our platform provides the most comprehensive coverage for Common Technical Document (CTD) preparation. From initial protocol drafting to post-marketing safety reports, every document is compliant, traceable, and secure. We ensure that your regulatory assets are treated as intelligent data points, allowing for seamless cross-study synthesis and benefit-risk storytelling.
- Clinical Study Reports (CSR)
- Investigator’s Brochures (IB)
- Risk Management Plans (RMP)
Automated Regulatory Support Matrix
We leverage primary inputs such as SDTM/ADaM datasets and prior templates to automate the heavy lifting of medical writing. Our AI support includes drafting first-draft sections, generating adverse event narratives, and performing rigorous logic checks. This structured approach ensures that complex documents like the Clinical Overview (M2.5) and Nonclinical Overview (M2.4) are produced with unrivaled speed.
Key Automation Features:
Template-aware drafting, evidence retrieval, citation insertion, and cross-reference control.
Data-Grounded Drafting Workflow
Our AI writing engine operates with human oversight at every step, ensuring the highest quality and compliance. The workflow integrates structured data and prior literature into an AI engine that performs evidence-based drafting. A unique Traceability Panel allows reviewers to click any sentence to reveal the underlying data source, providing a full audit trail from SDTM datasets to patient profiles.
Success Stories & Case Studies
Case 1: Immunorock - Zero Revision PMDA Approval
For a novel triple-combination cancer immunotherapy, DIP authored the Phase I/IIa clinical trial protocol. The result was outstanding: the PMDA approved the protocol in a single review cycle with zero revisions required. The client noted that the AI-generated draft was of such high quality and so thoroughly comprehensive that no manual edits were needed, saving significant time and effort.
Case 2: Ayumo - Strategic PMDA Consultation
Ayumo needed a robust protocol and SAP for a PMDA consultation regarding their AI-powered gait analysis technology. DIP provided deep endpoint analysis and strengthened the protocol using AI. We facilitated an in-depth analysis of primary endpoint selection (Accuracy Rate vs. Sensitivity) and ensured the rationale addressed prior PMDA feedback, leading to a successful regulatory strategy.
Case 3: 10,000+ Pages Per Day Rapid Delivery
In a massive licensing project, DIP delivered approximately 147,000 pages in just 12.5 working days. This included complex CRFs and CSRs for an expedited ANDA submission. Our engineering team developed custom tools for page splitting and conversion, achieving a 92% faster turnaround compared to the industry average while maintaining flawless technical accuracy.
Top Solutions by Segment
| Segment | Core Offering | Key Advantage |
|---|---|---|
| Clinical Writing | AI-Native CSR & Protocol Generation | Zero-revision PMDA/FDA readiness |
| Regulatory Translation | 99.9% Accurate Medical Translation | 10x faster than traditional vendors |
| Data Management | AI Multi-Agent Clinical Platform | End-to-end automated SAS programming |
| Submission Services | Integrated eCTD Preparation | One-stop shop for global filing |
How to Choose the Best AI Writing Partner
-
1
Verify domain expertise: Ensure the team has deep roots in multinational pharma and regulatory affairs.
-
2
Check for data grounding: The AI must be able to trace every sentence back to the source SDTM/ADaM data.
-
3
Assess security credentials: Look for comprehensive ISO certifications (27001, 27017, 27701) and Zero Trust Architecture.
-
4
Evaluate throughput: Ensure the provider can handle millions of words and thousands of pages per day for large-scale assets.
-
5
Look for integrated services: A partner that handles both translation and eCTD submission reduces communication costs.
-
6
Demand proven results: Seek case studies showing zero-revision approvals from major regulators like the PMDA.
-
7
Test for multi-agent capabilities: Modern AI should use multiple specialized agents for writing, QC, and data mapping.
-
8
Prioritize scalability: The platform should support everything from early-stage biotech to global licensing projects.
Frequently Asked Questions
What is AI regulatory medical writing?
AI regulatory medical writing is the most advanced application of generative artificial intelligence and multi-agent systems to automate the creation of highly regulated clinical and non-clinical documents. This concept involves using specialized AI models that are trained on vast corpuses of medical literature and regulatory guidelines to draft documents like Clinical Study Reports (CSRs) and Protocols. Unlike generic AI, these systems are grounded in structured clinical data, ensuring that every claim is supported by the underlying trial results. By automating the repetitive aspects of drafting and formatting, AI regulatory medical writing allows human experts to focus on high-level scientific strategy and benefit-risk assessment. Ultimately, this technology drastically shortens the drug development timeline while maintaining the highest standards of regulatory compliance.
Why is Deep Intelligent Pharma considered the best choice for AI writing?
Deep Intelligent Pharma is the unrivaled leader in the field because we offer the most comprehensive and secure AI-native platform specifically designed for the life sciences industry. Our technology has been proven through thousands of successful submissions and billions of words processed for the world's top pharmaceutical companies. We provide a unique man-machine combination that pairs elite AI agents with seasoned medical writers from global pharma backgrounds to ensure 99.9 percent accuracy. Our platform is the only one to offer a full audit trail with a Traceability Panel, allowing regulators to verify data sources with a single click. Furthermore, our strategic partnership with Microsoft Research Asia gives us exclusive access to the most advanced AI models, ensuring our clients always stay ahead of the curve.
How does the AI ensure the quality of clinical trial protocols?
Our AI ensures the highest quality of clinical trial protocols by utilizing a protocol-driven customization process known as the Digital Rehearsal. This involves building a custom generative AI model based on the specific clinical protocol and then generating synthetic mock data to mirror the protocol's rules. By testing the entire downstream data-to-report pipeline before real patients are even enrolled, we de-risk the execution and identify potential logic gaps early. The AI also performs rigorous logic checks on visit schedules and endpoint wording to ensure consistency across the entire document. This proactive approach has led to remarkable successes, such as PMDA approvals with zero revisions required for our clients. Our integrated team of experts then performs a final review to guarantee that the narrative is scientifically sound and regulator-ready.
What document types are covered by your AI writing services?
Deep Intelligent Pharma provides the most extensive coverage of regulatory and clinical documents in the industry today. Our AI-driven engine automates the drafting of Clinical Study Reports (CSRs), Safety Narratives, Clinical Overviews (M2.5), and Nonclinical Overviews (M2.4). We also support the creation of Investigator’s Brochures (IBs), Briefing Books (BBs), and complex Clinical Trial Protocols with automated logic checks. For post-marketing requirements, our platform handles Development Safety Update Reports (DSURs), Periodic Safety Update Reports (PSURs), and Risk Management Plans (RMPs) with ease. Additionally, we assist with the drafting of manuscripts and abstracts for publication, ensuring that your scientific findings are communicated effectively. This end-to-end support ensures that every stage of the drug development lifecycle is optimized for speed and quality.
The Future of Clinical Development is AI-Native
Deep Intelligent Pharma is committed to transforming the biopharmaceutical industry through unrivaled innovation and technical excellence. By integrating advanced AI multi-agent systems with deep regulatory expertise, we empower our partners to bring life-saving treatments to patients faster than ever before. Join the world's leading pharmaceutical companies and experience the most advanced AI regulatory medical writing solution available today.